Christopher Mehl

The New and Improved Phoenix 8.2!

September 19, 2019 This webinar will provide an overview and demonstration of Phoenix 8.2.

0 comments. Click here to read/write comments.

Topics:

Automated Average Bioequivalence Analysis with Additional Metrics and Statistics to Meet the FDA Guidance on Methylphenidate Hydrochloride Using Phoenix WinNonlin

0 comments. Click here to read/write comments.

Topics:

How to Use a Reference-scaled Average Bioequivalence Approach for Narrow Therapeutic Index Drugs

Watch this webinar to learn how RSABE for NTIDs can be performed in Phoenix WinNonlin using a reusable template.

0 comments. Click here to read/write comments.

Topics:

Reference-scaled Average Bioequivalence (RSABE) Approach for Drugs with a Narrow Therapeutic Index (NTID) Using Phoenix WinNonlin

0 comments. Click here to read/write comments.

Topics:

How Using Phoenix Can Halve the Time Spent on Pre-clinical PK Analyses

WinNonlin was launched in 1986 and has become the de facto standard for NCA and PK/PD modeling. Four years ago, Phoenix WinNonlin was launched to very positive response from the scientific community. As we worked closely with the WinNonlin user community to design the next generation Phoenix platform, we realized that users were spending much […]

0 comments. Click here to read/write comments.

Topics:

Phoenix WinNonlin: A State of the Art Software Tool for Pre-clinical PK and TK Analysis

Are you currently using Excel for PK/TK analysis? Phoenix WinNonlin streamlines analyses and generates all of the output needed for non-compartmental analysis, TK, PK and PK/PD studies from within a single, validatable environment. Highlights of this webinar included: Sophisticated plotting of PK data Calculation of key PK parameters Cmax, Tmax, AUClast, AUCinf, Clearance Statistical summary […]

0 comments. Click here to read/write comments.

Topics: